LON:HYG Seneca Growth Capital VCT 4/30/2026 Earnings Report GBX 8.50 0.00 (0.00%) As of 05/14/2026 ProfileEarnings History Seneca Growth Capital VCT EPS ResultsActual EPS-GBX 0.20Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ASeneca Growth Capital VCT Revenue ResultsActual Revenue$0.18 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ASeneca Growth Capital VCT Announcement DetailsQuarterDate4/30/2026TimeN/AConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Seneca Growth Capital VCT Earnings HeadlinesSeneca Growth Capital VCT Publishes 2025 Annual Report and Updates NAVs Ahead of June AGMApril 30, 2026 | tipranks.comSeneca Growth Capital VCT PLCDecember 9, 2025 | barrons.comThe chokepoint supplier behind SpaceX's $1.75 trillion empireWhen Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession. The world's largest supercomputer requires power equipment that takes 120 weeks to build, and Musk built Colossus in just 122 days. One small American company is positioned to close that gap faster than anyone else, yet Wall Street still prices it like an afterthought. Dylan Jovine has the full story and the ticker.May 16 at 1:00 AM | Behind the Markets (Ad)Seneca Growth Capital VCT PLC Announces Share Buy-BackNovember 28, 2025 | tipranks.comSeneca Growth Capital VCT Plc: Insider Share Purchase by Advisory Committee MemberOctober 21, 2025 | tipranks.comSeneca Growth Capital VCT PLC Releases Half-year ReportSeptember 26, 2025 | tipranks.comSee More Seneca Growth Capital VCT Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Seneca Growth Capital VCT? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Seneca Growth Capital VCT and other key companies, straight to your email. Email Address About Seneca Growth Capital VCTSeneca Growth Capital VCT (LON:HYG) plc is a venture capital trust specializes in growth capital. It invests in emerging biotechnology companies. It prefers to invest in unquoted and quoted MedTech companies. The fund seeks to invest in the United Kingdom, IIe-de-France, Burgundy, France, European Developed Markets. It typically invests in companies with sales greater than £10 million ($11.90 million), gross margin greater than 50% and operating margin greater than 10%.View Seneca Growth Capital VCT ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Peloton Stock Gives Back Gains After Upbeat Earnings ReportDatavalut Gains Traction: 5 Reasons to Sell NowTMC Stock: Why This Pre-Revenue Miner Is Worth WatchingViking Sails to All-Time Highs—Fundamentals Signal More to ComeYETI Rallies After Earnings Beat and Raised OutlookAeluma's Post-Earnings Dip Creates a Buying OpportunityCisco’s Vertical Rally May Still Be in the Early Innings Upcoming Earnings Palo Alto Networks (5/19/2026)Home Depot (5/19/2026)Keysight Technologies (5/19/2026)Analog Devices (5/20/2026)Intuit (5/20/2026)NVIDIA (5/20/2026)Lowe's Companies (5/20/2026)Medtronic (5/20/2026)Target (5/20/2026)TJX Companies (5/20/2026) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
